Biological Effects of Short-Term or Prolonged Administration of 9-[2-(Phosphonomethoxy)Propyl]Adenine (Tenofovir) to Newborn and Infant Rhesus Macaques

The reverse transcriptase inhibitor 9-[2-(phosphonomethoxy)propyl]adenine (PMPA; tenofovir) was previously found to offer strong prophylactic and therapeutic benefits in an infant macaque model of pediatric human immunodeficiency virus (HIV) infection. We now summarize the toxicity and safety of PMP...

詳細記述

書誌詳細

出版年:	Antimicrob Agents Chemother
主要な著者:	Van Rompay, Koen K. A., Brignolo, Laurie L., Meyer, Dennis J., Jerome, Christopher, Tarara, Ross, Spinner, Abigail, Hamilton, Marta, Hirst, Linda L., Bennett, David R., Canfield, Don R., Dearman, Trish G., Von Morgenland, Wilhelm, Allen, Phil C., Valverde, Celia, Castillo, Alesha B., Martin, R. Bruce, Samii, Valerie F., Bendele, Ray, Desjardins, John, Marthas, Marta L., Pedersen, Niels C., Bischofberger, Norbert
フォーマット:	Artigo
言語:	Inglês
出版事項:	American Society for Microbiology (ASM) 2004
主題:	Antiviral Agents
オンライン･アクセス:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC400569/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15105094/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.48.5.1469-1487.2004
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!